Work

ME13 Outlook for future treatment strategy on NSCLC with driver oncogene alterations

Year: 2022

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.05.093

Author: Pasi A. Janne

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4286515985

Cites:

Cited by:

Related to: 10